Compounded bioidentical menopausal hormone therapy

Fertility and Sterility

Volumn 98, Issue 2, 2012, Pages 308-312

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTRONE; PROGESTERONE;

ARTICLE; DIET SUPPLEMENTATION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG FORMULATION; DRUG LABELING; DRUG LEGISLATION; DRUG QUALITY; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; HORMONAL THERAPY; HUMAN; MENOPAUSE; PATIENT COUNSELING; PRESCRIPTION; PRIORITY JOURNAL;

BIOLOGICAL AGENTS; DRUG COMPOUNDING; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MENOPAUSE; MIDDLE AGED; REPRODUCTIVE MEDICINE; SOCIETIES, MEDICAL; UNITED STATES; WOMEN'S HEALTH;

EID: 84864457010     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2012.06.002     Document Type: Article

References (19)

1. J.E. Rossouw, G.L. Anderson, R.L. Prentice, A.Z. LaCroix, C. Kooperberg, and M.L. Stefanick Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. Writing Group for the Women's Health Initiative Investigators JAMA 288 2002 321 333
2. S. Wassertheil-Smoller, S.L. Hendrix, M. Limacher, G. Heiss, C. Kooperberg, and A. Baird Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. WHI Investigators JAMA 289 2003 2673 2684
3. J.E. Rossouw, R.L. Prentice, J.E. Manson, L. Wu, D. Barad, and V.M. Barnabei Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause [published erratum appears in JAMA 2008;299:1426] JAMA 297 2007 1465 1477
4. M.S. Rosenthal The Wiley Protocol: an analysis of ethical issues Menopause 15 2008 1014 1022
5. L.A. Boothby, P.L. Doering, and S. Kipersztok Bioidentical hormone therapy: a review Menopause 11 2004 356 367
6. J.A. Drisko "Natural" isomolecular hormone replacement: an evidence-based medicine approach Int J Pharmaceut Compounding 4 2000 414 420
7. U.S. Food and Drug Administration. FDA takes action against compounded menopause hormone therapy drugs. Silver Spring (MD): FDA; 2008. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2008/ucm116832.htm. Retrieved February 15, 2012.
8. U.S. Food and Drug Administration. Report: limited FDA survey of compounded drug products. Silver Spring (MD): FDA; 2009. Available at: http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/ PharmacyCompounding/ucm155725.htm. Retrieved February 15, 2012.
9. American College of Obstetricians and Gynecologists Use of botanicals for management of menopausal symptoms. ACOG Practice Bulletin 28 2001 ACOG Washington, DC
10. R.L. Flyckt, J. Liu, H. Frasure, K. Wekselman, A. Buch, and S.A. Kingsberg Comparison of salivary versus serum testosterone levels in postmenopausal women receiving transdermal testosterone supplementation versus placebo Menopause 16 2009 680 688
11. J.G. Lewis, H. McGill, V.M. Patton, and P.A. Elder Caution on the use of saliva measurements to monitor absorption of progesterone from transdermal creams in postmenopausal women Maturitas 41 2002 1 6
12. P.T. Ellison Human salivary steroids: methodological considerations and applications in physical anthropology Am J Phys Anthropol 31 Suppl 9 1988 115 142
13. P. Hardiman, M. Thomas, V. Osgood, V. Vlassopoulou, and J. Ginsburg Are estrogen assays essential for monitoring gonadotropin stimulant therapy? Gynecol Endocrinol 4 1990 261 269
14. G.G. Klee, and D.W. Heser Techniques to measure testosterone in the elderly Mayo Clin Proc 75 Suppl 2000 S19 S25
15. P.M. Meulenberg, H.A. Ross, L.M. Swinkels, and T.J. Benraad The effect of oral contraceptives on plasma-free and salivary cortisol and cortisone Clin Chim Acta 165 1987 379 385
16. B.G. Wren, K. McFarland, L. Edwards, P. O'Shea, S. Sufi, and B. Gross Effect of sequential transdermal progesterone cream on endometrium, bleeding pattern, and plasma progesterone and salivary progesterone levels in postmenopausal women Climacteric 3 2000 155 160
17. Bolaji II, D.F. Tallon, E. O'Dwyer, and P.F. Fottrell Assessment of bioavailability of oral micronized progesterone using a salivary progesterone enzymeimmunoassay Gynecol Endo-crinol 7 1993 101 110
18. H. Raff, J.L. Raff, E.H. Duthie, C.R. Wilson, E.A. Sasse, and I. Rudman Elevated salivary cortisol in the evening in healthy elderly men and women: correlation with bone mineral density J Gerontol A Biol Sci Med Sci 54 1999 M479 M483
19. D.T. Zava, C.M. Dollbaum, and M. Blen Estrogen and progestin bioactivity of foods, herbs, and spices Proc Soc Exp Biol Med 217 1998 369 378